Interventional cardiology devices are medical devices which are introduced to treat the heart diseases. The most common type of heart disease is Coronary Heart Disease (CAD). It is a branch of cardiology that specifically deals with the catheter-based treatments such as an aneurysm, CAD, congenital heart defect, and others. Catheter performs the whole procedure by using fluoroscopy. Interventional cardiology provides the fast recovery, short hospital stay, reduces the complications, and controls the bleeding.
Global Interventional Cardiology Devices Market Size & Growth:
The global interventional cardiology devices market is envisaged to reach USD 22.15 Billion by 2024 from USD 15.01 Billion in 2018, at a CAGR close to 7.6% during the forecast period. The key factors leading the interventional cardiology devices market are growing geriatric population, increasing prevalence of CAD, and technological advancements in interventional cardiology devices. The interventional cardiology market size is growing rapidly in emerging economies due to the technological advancements in cardiology. Stringent regulatory approvals and reimbursement issues are restraining the market growth during the forecast period. The advent of bioresorbable stents is creating opportunities for the interventional cardiology and peripheral vascular devices market which are more profitable. According to the reports by WHO (World Health Organization), the total death of people caused by CAD are nearly 11.5 Million. Also, the rising demands for the minimally invasive surgeries are leading the market
Global Interventional Cardiology Devices Market Segments Share:
By considering the segmentation, the interventional cardiology devices market is categorised by product type, end-users, and geography. By product type, the market is classified into stents, catheters, interventional cardiology systems, PTCA (Percutaneous Transluminal Coronary Angioplasty), PTCA balloons, and others. Stents have taken up the majority interventional cardiology devices market share. Stents are again segmented into bare metal stents, drug-eluting, and bioresorbable stents. Among these, drug-eluting stents are holding the greater demand, owing to the higher efficiency of treatment, and reduces the in-stent restenosis. By geography, the market is segmented into the Asia Pacific, North America, Europe, South America, and the Middle East and Africa. North America region is envisaged to continue the pace as a leading region of interventional cardiology devices. Advanced healthcare infrastructure and high adoption rate of medical devices are Catheter which indicates
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.